Advanced Biomed Inc. ADVB
6.38
0.07
1.11%
as of 25 Sep
- Market cap
- $10.4M
- P/E
- 1.3×
Follow ADVB
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| 79.17% | 86.84% | (144.85%) | 0.00% |
+6 more TTM periods Free account |
|
| 55.78% | 57.12% | (108.29%) | (47.52%) | ||
ROIC |
(29.27%) | (28.55%) | (543.89%) | (309.33%) | |
Return on Tangible Assets |
57.47% | 45.80% | (109.74%) | (99.71%) | |
Free Cash Flow per Share |
(2.29) | (5.65) | (5.93) | (5.71) | |
Free Cash Flow |
(2.94) | (6.11) | (6.42) | (5.86) | |
Capital Expenditures |
(0.04) | (0.04) | (0.01) | (0.03) | |
Piotroski F-Score |
3.00 | 3.00 | 0.00 | 0.00 | |
| Other line items | |||||
Cash ROIC |
(24.62%) | (50.28%) | (113.16%) | (91.81%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.55) | (1.39) | 1.90 | 1.79 | |
Depreciation/Fixed assets |
3.67 | 3.43 | 1.03 | 2.75 | |
Capex/Depreciation |
(0.11) | (0.11) | (0.05) | (0.09) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.26) | (5.62) | (5.92) | (5.68) | |
Capex per Share |
(0.03) | (0.03) | (0.01) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates